[The achievement of prolonged effect with dl-1-[3'-hydroxyphenyl]-2-aminoethanol (Novadral, Regadrin)].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D003692:Delayed-Action Preparations; D003911:Dextrans / Q000494:pharmacology; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D051379:Mice; D009655:Octopamine / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D011205:Povidone / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical
D003692:Delayed-Action Preparations; D003911:Dextrans; D009655:Octopamine; D011205:Povidone
Die Erzeilung von Langzeiteffekten mit DL-1-3'-Hydroxyphenyl]-2-aminoäthanol (Novadral, Regadring)]